Table 1 Characterization of Mitoxantrone thermosensitive liposomes.

From: Effects of the mitoxantrone thermosensitive liposome nanodelivery system on prostate cancer in vivo and in vitro

Batch

Lipid composition (molar ratio)

Particle size (nm)

Zeta potential (mV)

pH

Osmotic pressure (mOsmol/Kg)

EE (%)

Drug content (mg/mL)

1

DPPC: MSPC: DSPE-mPEG2000 (90:10:4)

98.61

−34.52

6.52

309

98.66

1.10

2

DPPC: MSPC: DSPE-mPEG2000 (90:10:4)

101.60

−32.35

6.51

307

98.34

1.07

3

DPPC: MSPC: DSPE-mPEG2000 (90:10:4)

100.10

−33.66

6.55

312

98.22

1.03

Mean

DPPC: MSPC: DSPE-mPEG2000 (90:10:4)

100.10 ± 1.50

−33.51 ± 1.09

6.53 ± 0.02

309 ± 3

98.41 ± 0.23

1.07 ± 0.04

  1. EE encapsulation efficiency.